This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Myome, Inc.. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2026
Title: Kate M. Im and Polygenic Risk Assessment for IVF.
Introduction
Kate M. Im is an inventor based in Ellicott City, Maryland. Her patent work includes a method for assessing disease risk in embryos and potential children using genetic information and polygenic risk scores.
Latest Patents
Im is associated with one patent, 1 patent: “Polygenic Risk Score for In Vitro Fertilization.” The invention describes constructing an embryo’s genome using genetic variants, parental haplotypes, and their transmission probabilities. A polygenic risk score is then used to estimate disease risk and assess the inheritance of disease-causing variants or haplotypes. The methods also address estimating a range of disease risks for potential children of a mother and a potential sperm donor, as well as determining disease risk in an individual.
Career Highlights
Im is associated with Myome, Inc. Her patent focuses on applying genetic analysis to reproductive medicine, with the aim of informing assessments of inherited disease risk.
Collaborations
Im’s listed coworkers include Luisa Galhardo and Elan Bechor. The patent’s subject matter reflects work involving genetic data, embryo assessment, and reproductive health.
Conclusion
Kate M. Im’s patent contribution centers on using polygenic risk scores and inherited genetic information to evaluate disease risk in IVF embryos and potential children.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile